Clinical Trials Browser

Phase 1/2 × Terminated × Neoplasms, Squamous Cell × Clear all

NCT04496674 2025-04-23

2019-004849-32

Phase 1/2 Terminated

Neoplasms, Squamous Cell

NCT00401401 2011-12-23

Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer

Phase 1/2 Terminated

30 enrolled 13 charts

Head and Neck Neoplasms, Neoplasms, Squamous Cell